Suppr超能文献

蒙古综合医院门诊患者中乙型和丙型肝炎病毒标志物的流行情况。

Prevalence of hepatitis B and C virus markers in outpatients of Mongolian general hospitals.

作者信息

Fujioka S, Shimomura H, Ishii Y, Kondo J, Fujio K, Ikeda F, Miyake M, Kusachi S, Tsuji T

机构信息

First Department of Internal Medicine, Okayama University Medical School.

出版信息

Kansenshogaku Zasshi. 1998 Jan;72(1):5-11. doi: 10.11150/kansenshogakuzasshi1970.72.5.

Abstract

In East Asian countries, the prevalence of viral hepatitis has been reported to be high, but precise data for each country remained to be investigated. Here we report the prevalence of viral markers of hepatitis B and hepatitis C in outpatient volunteers visiting two general hospitals in Ulaanbaatar, Mongolia. One hundred fifty sera were tested for HBs antigen (HBsAg), anti-HBs, and anti-HCV by Counting Immunoassay. The backgrounds of groups of patients positive for HBsAg and negative for anti-HCV (group 1; n = 18), negative for HBsAg and positive for anti-HCV (group 2; n = 47), positive for both HBsAg and anti-HCV (group 3; n = 25), and negative for both HBsAg and anti-HCV (group 4; n = 60) were compared. The prevalence of HBsAg, anti-HBs, and anti-HCV in this study group was 28.7%, 39.3% and 48.0%, respectively. Subjects of group 1 (mean +/- SD; 31.3 +/- 12.4 years old) were younger than those of group 4 (39.2 +/- 14.3; p < 0.05), while patients of group 2 (48.7 +/- 15.5) were older than those of group 4 (p < 0.01). More group 2 subjects had histories of jaundice (23/47) than those of group 4 (15/60; p < 0.05). Transaminase levels were higher in group 1 (median (range) IU/l of AST, ALT; 29 (13-95), 32 (9-144) and group 3 (25 (15-187), 22 (8-185)) than in group 4 (18 (9-13), 15 (6-133); p < 0.05, p < 0.005 vs. group 1, and p < 0.005, p < 0.001 vs. group 3, respectively). In HBsAg-negative subjects, those with higher titers of anti-HCV (cut-off index > 15) were older, and had more histories of jaundice and higher levels of AST and ALT than anti-HCV negative subjects (50.3 +/- 14.8 vs. 39.1 +/- 14.3, p < 0.01; 15/28 vs. 15/60, p < 0.01; 22.5 (12-127) vs. 18 (9-93), p < 0.05; 20.5 (7-362) vs. 15 (6-133), p < 0.05; respectively). In conclusion, this preliminary surveillance for hepatitis B and C viral markers showed that both hepatitis viruses are prevalent and may cause liver diseases in Mongolia. A nation-wide survey for these viruses should be urged and preventive measures should be taken to suppress the spread and development of liver diseases in this country.

摘要

据报道,东亚国家病毒性肝炎的患病率较高,但各国的精确数据仍有待调查。在此,我们报告了在蒙古乌兰巴托的两家综合医院就诊的门诊志愿者中乙型肝炎和丙型肝炎病毒标志物的患病率。通过计数免疫分析法对150份血清进行了乙肝表面抗原(HBsAg)、乙肝表面抗体和丙肝抗体检测。比较了HBsAg阳性且丙肝抗体阴性组(第1组;n = 18)、HBsAg阴性且丙肝抗体阳性组(第2组;n = 47)、HBsAg和丙肝抗体均阳性组(第3组;n = 25)以及HBsAg和丙肝抗体均阴性组(第4组;n = 60)患者的背景情况。该研究组中HBsAg、乙肝表面抗体和丙肝抗体的患病率分别为28.7%、39.3%和48.0%。第1组受试者(平均±标准差;31.3±12.4岁)比第4组受试者年轻(39.2±14.3;p < 0.05),而第2组患者(48.7±15.5)比第4组患者年龄大(p < 0.01)。第2组有黄疸病史的受试者(23/47)比第4组(15/60;p < 0.05)更多。第1组(天冬氨酸转氨酶、丙氨酸转氨酶的中位数(范围)IU/l;29(13 - 95),32(9 - 144))和第3组(25(15 - 187),22(8 - 185))的转氨酶水平高于第4组(18(9 - 13),15(6 - 133);与第1组相比,p < 0.05,p < 0.005;与第3组相比,p < 0.005,p < 0.001)。在HBsAg阴性受试者中,丙肝抗体滴度较高(临界指数>15)的受试者比丙肝抗体阴性受试者年龄大,有更多黄疸病史,天冬氨酸转氨酶和丙氨酸转氨酶水平更高(50.3±14.8对39.1±14.3,p < 0.01;15/28对15/60,p < 0.01;22.5(12 - 127)对18(9 - 93),p < 0.05;20.5(7 - 362)对15(6 - 133),p < 0.05;分别)。总之,这项对乙肝和丙肝病毒标志物的初步监测表明,这两种肝炎病毒在蒙古都很普遍,可能导致肝脏疾病。应敦促在全国范围内对这些病毒进行调查,并应采取预防措施以抑制该国肝脏疾病的传播和发展。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验